AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
AptarGroup, Inc. (ATR) Segment President Marc Prieur sold 2,000 common shares on November 2, 2026, at a weighted average price of $141.9872 per share. The shares were sold in multiple transactions priced from $141.57 to $142.29. Marc Prieur directly held 13,823 shares after the sale. The sale was not reported as made under a Rule 10b5-1 plan.
Marc Prieur, an officer of AptarGroup, Inc. (ATR), reported a planned sale of 2,000 common shares, with an aggregate market value of $274,000.00 and an approximate sale date of November 2, 2026, through UBS Switzerland AG.
The notice identifies the securities as RSUs and PSUs and reports 66,543,252 shares outstanding.
AptarGroup, Inc. reported third-quarter 2026 net sales of $1.02 billion, up 6% from $961.1 million a year earlier. Core sales, excluding acquisitions, deconsolidation and changes in foreign currency rates, increased 5%. Beauty and Closures core sales grew 8% and 11%, respectively; Pharma core sales grew 1%, as growth in consumer healthcare and injectables offset lower emergency-medicine sales.
Net income attributable to AptarGroup was $32.6 million, compared with $127.9 million in the third quarter of 2025; operating income was $135.0 million versus $136.9 million. After concluding it had lost control of its Russian subsidiary, AptarGroup deconsolidated it effective September 21, 2026, recording a $58.0 million loss. The company also reported $30.0 million of subsidiary cash it could no longer access; Russian operations are no longer included in consolidated sales, earnings or net assets.
Operating cash flow was $389.8 million for the first nine months of 2026, compared with $386.3 million a year earlier. AptarGroup repurchased approximately 1.3 million shares for $180.0 million over that period, with $420.0 million remaining under the $600.0 million authorization as of September 30, 2026. The third-quarter dividend per common share was $0.48, compared with $0.45 a year earlier.
AptarGroup, Inc. (ATR) reported third-quarter 2026 sales of $1.02 billion, up 6% year over year, with core sales up 5%. Reported sales growth was 2% in Pharma, 9% in Beauty and 11% in Closures. Net income attributable to AptarGroup was $32.6 million and diluted EPS was $0.51, compared with $127.9 million and $1.92 a year earlier. Adjusted EPS was $1.52 versus $1.62, and adjusted EBITDA margin was 21.3% versus 23.2%.
Aptar deconsolidated its Russian subsidiary after a governmental decree placed it under external administration and Aptar lost control. The combined impact was $60.4 million after tax, or $0.94 per diluted share; Aptar recorded a $58.0 million loss on deconsolidation, including approximately $30.0 million of cash held by the subsidiary. Nine-month sales were $3.03 billion, up 8%, while adjusted EPS declined 10% to $4.13.
Aptar expects fourth-quarter adjusted EPS of $1.39 to $1.47, assuming a 17.5% to 19.5% effective tax rate and a 1.12 Euro to USD exchange rate. The Board approved increasing the quarterly dividend from $0.48 to $0.50 per share, payable December 3, 2026, to holders of record November 12, 2026. Aptar repurchased approximately 234,000 shares for $30 million during the quarter.
APTARGROUP, INC. (ATR) reports that a decree by the President of the Russian Federation has placed its Russian subsidiary, OOO Aptar Vladimir, under temporary external administration. The company states it is assessing the situation and its options and is committed to taking all necessary steps to protect its rights as shareholder.
As of December 31, 2025, Aptar Vladimir represented less than 0.6% of AptarGroup’s consolidated net sales and operating income and less than 1% of consolidated assets, indicating limited direct financial exposure. AptarGroup highlights multiple uncertainties, including potential further actions by Russian authorities, legal and sanctions developments, and possible accounting consequences such as impairment of its investment.
APTARGROUP, INC. (ATR) reported the initial beneficial ownership of its Interim Chief Accounting Officer, Daniel Ackerman. He holds stock options on 17,500 shares of common stock at an exercise price of $74.79 expiring February 10, 2027, plus additional option grants on 2,971 shares at $111.38 expiring March 15, 2033, 2,485 shares at $141.00 expiring March 15, 2034, 2,451 shares at $147.84 expiring March 17, 2035, and 2,967 shares at $123.97 expiring March 19, 2036.
For each of these option awards, the filing states that the option vests in three equal installments beginning on the first anniversary of the grant date. Ackerman also reports direct ownership of 32,779 shares of APTARGROUP common stock.
APTARGROUP, INC. (ATR) reported that Aditya J. Gandhi, Vice President, Chief Accounting Officer and principal accounting officer, has decided to resign effective September 11, 2026 to pursue another opportunity outside the greater Chicago area. The company states his resignation is not due to any disagreement regarding operations, policies or practices.
Effective as of the separation date, the Board appointed Daniel Ackerman
APTARGROUP, INC. (ATR) reported that Chief Human Resources Officer Shiela Vinczeller sold 765 shares of common stock on September 2, 2026 in a sale classified as an open market or private transaction. The weighted average sale price was $130.3693 per share, with individual trades between $130.25 and $130.45. Following this transaction, she directly holds 26,313 shares of AptarGroup common stock. No Rule 10b5-1 trading plan is reported for this sale.
APTARGROUP, INC. (ATR) has an affiliate officer, Shiela Pallerne Vinczeller, filing a notice of proposed sale of 765 shares of common stock under Rule 144, to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The shares relate to restricted stock granted on November 5, 2019 under a registered plan for services rendered. The notice also reports that Vinczeller sold 3,555 shares of AptarGroup common stock in a prior transaction on June 4, 2026.
APTARGROUP, INC. (ATR) reported that President and CEO Gael Touya received equity awards on September 1, 2026. He was granted stock options covering 9,531 shares of common stock at an exercise price of $130.92 per share, which vest in three equal installments starting on the first anniversary of the grant date, with the remaining two installments vesting on March 19 of each succeeding year. On the same date, he also received a separate grant of 2,637 shares of common stock, bringing his directly held common shares to 31,739. No Rule 10b5-1 trading plan is reported for these awards.